Open Access

[Retracted] miR‑200b and miR‑200c co‑contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases

  • Authors:
    • Jue Liu
    • Xiaobo Zhang
    • Yuliang Huang
    • Qunfeng Zhang
    • Jianbin Zhou
    • Xiaodi Zhang
    • Xiaoxu Wang
  • View Affiliations

  • Published online on: March 4, 2025     https://doi.org/10.3892/ol.2025.14951
  • Article Number: 209
  • Copyright : © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Lett 17: [Related article:] 1453–1460, 2019; DOI: 10.3892/ol.2018.9745

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the flow cytometric assay data shown in Fig. 2 on p. 1456 had already appeared in a pair of previously published articles written by different authors at different research institutes. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Letters, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.

Related Articles

Journal Cover

April-2025
Volume 29 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu J, Zhang X, Huang Y, Zhang Q, Zhou J, Zhang X and Wang X: [Retracted] miR‑200b and miR‑200c co‑contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases . Oncol Lett 29: 209, 2025.
APA
Liu, J., Zhang, X., Huang, Y., Zhang, Q., Zhou, J., Zhang, X., & Wang, X. (2025). [Retracted] miR‑200b and miR‑200c co‑contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases . Oncology Letters, 29, 209. https://doi.org/10.3892/ol.2025.14951
MLA
Liu, J., Zhang, X., Huang, Y., Zhang, Q., Zhou, J., Zhang, X., Wang, X."[Retracted] miR‑200b and miR‑200c co‑contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases ". Oncology Letters 29.4 (2025): 209.
Chicago
Liu, J., Zhang, X., Huang, Y., Zhang, Q., Zhou, J., Zhang, X., Wang, X."[Retracted] miR‑200b and miR‑200c co‑contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases ". Oncology Letters 29, no. 4 (2025): 209. https://doi.org/10.3892/ol.2025.14951